Please login to the form below

Not currently logged in
Email:
Password:

ABPI appoints Pfizer’s Colette Goldrick as first Northern Ireland director

Will develop relationships with key opinion leaders in region

ABPI Colette GoldrickThe Association of the British Pharmaceutical Industry (ABPI) has appointed Pfizer Europe's former head of head of public affairs and policy Colette Goldrick as its first Northern Ireland director.

A native of Northern Ireland, Goldrick will be tasked with the identification, establishment and development of relationships with key opinion leaders and decision makers in the nation.

“The ABPI believes that Northern Ireland represents a significant opportunity for the bio-pharmaceutical industry in terms of the growing life science agenda, arising from world class capability at Queen's University Belfast, the University of Ulster and the Science Park,” said the ABPI's chief executive Stephen Whitehead.

“Our partnership based approach will seek to engage all stakeholders in supporting healthcare professionals to effectively utilise innovative medicines and improve patient health.”

Goldrick has a strong pedigree within the pharma industry, serving in senior positions in public affairs and communications at both Pfizer and GlaxoSmithKline.

Prior to her most recent role at Pfizer, she was Pfizer UK's head of communications and corporate affairs director. During her time at the pharma giant, she won Communiquétor of the Year at the Communiqué Awards 2008. At GSK, Goldrick served in several roles, rising to head of communications.

6th November 2012

From: Sales, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics